Caroline Chen covers health care for ProPublica. Previously, she worked at Bloomberg News, where she wrote about Valeant Pharmaceutical’s use of a mail order pharmacy to boost reimbursements for its drugs, the tactics used by a rare disease drugmaker to scare patients into staying on therapy, and the plight of medically complex babies who get stranded in hospitals because of a lack of home-care nurses. She received her Master’s degree from the Stabile Program in Investigative Journalism at Columbia University, where she was awarded a Pulitzer Traveling Fellowship.
The New Jersey hospital is taking corrective action after a government investigation spurred by ProPublica’s reporting found that its transplant team was failing to learn from surgical errors.
We’re giving away 20 scholarships to help students attend journalism conferences like NABJ-NAHJ, ONA and IRE. Apply!
Andy Jurtschenko told his children that he didn’t want to be a burden on them. But after he suffered brain damage during a heart transplant at a New Jersey hospital, his medical team deflected their request for a DNR.
The bureau is looking at whether the hospital may have defrauded Medicare and Medicaid as it kept a vegetative patient on life support for the sake of its metrics.
Newark Beth Israel acted after our report that its transplant program kept a patient alive to improve its metrics, while barely consulting his family.
Feds to Investigate Hospital Alleged to Have Kept Vegetative Patient Alive to Game Transplant Survival Rates
Spurred by a ProPublica investigation, the U.S. Centers for Medicare and Medicaid Services will also carry out an inquiry.
“It’s Very Unethical”: Audio Shows Hospital Kept Vegetative Patient on Life Support to Boost Survival Rates
Darryl Young suffered brain damage during a heart transplant at Newark Beth Israel and never woke up. But, hardly consulting his family, doctors kept him alive for a year to avoid federal scrutiny.
This month, we reported R3 Stem Cell was promoting unapproved birth tissue products for a wide range of diseases. This week, the FDA put the company on notice.
How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry.
A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them.
If you’re considering whether to enroll in a trial of an experimental drug, here’s what you need to know.
ProPublica is seeking your help in finding out how birth tissue donated by mothers is used in research and by industry.
Whether they came to the U.S. alone, or were forcibly separated from their families at the border, despondent minors are often pressured into taking psychotropic drugs without approval from a parent or guardian.
As pharma companies underwrite three-fourths of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.